Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07927322
Not yet recruitingNCT07927322ClinicalTrials.gov record

Patient-Reported and Functional Outcomes After Nonoperative Management of Minimally Displaced Femoral Neck Fractures

Femoral Neck Fractures

THE QUICK READ

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type
Observational
Phase
Not applicable / not listed
Age range
65 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
100 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The goal of this observational study is to understand how hip function changes over 24 months in adults with minimally displaced femoral neck fractures who are treated without surgery. The study will also describe outcomes for patients who receive surgery as part of their usual clinical care.

Participants will:

  • Receive treatment chosen through shared decision-making with their orthopaedic surgeon; the study will not change their clinical care.
  • Complete questionnaires about hip function, pain, quality of life, mobility, and daily activities.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Acute minimally displaced femoral neck fracture, valgus-impacted or nondisplaced
  • AO/OTA 31-B1 fracture pattern
  • Presentation within 7 days of injury

Exclusion Criteria:

  • Displaced femoral neck fracture
  • Pathologic fracture
  • Periprosthetic fracture
  • Open fracture
  • Previous ipsilateral femoral neck fracture
  • Previous isilateral hip arthroplasty
  • Polytrauma
  • Delayed presentation to ED

Study population

Patients presenting to Stanford Health Care Emergency Department or Orthopaedic Trauma Clinic

Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not reported
Masking
Not reported
Non-operative management group

Participants treated non-operatively for femoral neck fractures

Other: Non-operative management

Operative management group

Participants treated operatively for femoral neck fractures

Procedure: Operative management

Non-operative management OTHER

Patient reported outcome measures and functional outcomes at 6 weeks, 4 months, 12 months and 24 months post injury

Operative management PROCEDURE

Patient reported outcomes and functional outcomes at 6 weeks, 4 months, 12 months, and 24 months post injury

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Changes in Modified Harris Hip Score

Time frame: 6 weeks, 4 months, 12 months post injury

Changes from baseline to 12 months. The modified Harris Hip Score (mHHS) is a measure of physical function scored from 0 to 100, where higher scores indicate better physical function and lower scores indicate worse physical function.

Secondary measures

Failure of non-operative management

Time frame: 6 weeks, 4 months, 12 months, 24 months post injury

Failure rate of non-operative management defined as conversion to hemiarthroplasty, or total hip arthroplasty.

Changes in Oxford Hip Score

Time frame: 6 weeks, 4 months, 12 months, 24 months post injury

Changes from baseline to 24 months. The Oxford Hip Score is a measure of physical function scored on the 0 to 48 scale. Each of the 12 items scored 0 to 4, higher scores indicating better physical function and lower scores indicate worse physical function.

Changes in health related quality of life

Time frame: 6 weeks, 4 months, 12 months, 24 months post injury

Changes from baseline to 24 months in EQ-5D-5L. EQ-5D-5L is a patient reported outcome measure to measure health related quality of life scored on a 5 to 25 scale where higher scores indicate worse health status and lower scores indicates better health status.

Changes to Barthel Index

Time frame: 6 weeks, 4 months, 12 months, 24 months post injury

Changes from baseline to 24 months. The Barthel index is a measure of a participant's level of functional independence in basic activities of daily living. It is scored on a 0-100 scale, where higher score indicating higher level of independence and lower score indicating higher level of dependence.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (0)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

No locations are listed. Use the official study contact.

Study team and timeline

Lead sponsor
Stanford University
Study start
2026-11 Estimated
Primary completion
2028-12 Estimated
Study completion
2028-12 Estimated
First posted
Nov 10, 2026 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Patient-Reported and Functional Outcomes After Nonoperative Management of Minimally Displaced Femoral Neck Fractures: A Prospective Cohort Study

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026